AstraZeneca PLC (AZN.L) Stock Analysis

Free AI-powered analysis and research for AstraZeneca PLC stock

Sector: Healthcare

Analyze AstraZeneca PLC (AZN.L) Stock

AstraZeneca PLC (AZN.L) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into AZN.L stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for AstraZeneca PLC stock.

Analyze AZN.L Now →

📰 Latest Update

Citi raises AstraZeneca earnings forecast and maintains 'buy' rating ahead of second-half pipeline catalysts

Thu, April 30, 2026 at 12:32 PM UTC 3 min read

Citi has raised its earnings forecast for AstraZeneca (AZN.L) while maintaining a 'buy' rating, citing potential catalysts from the company's second-half pipeline. This adjustment reflects confidence in AstraZeneca's upcoming product launches, which could drive revenue growth and enhance shareholder value. Investors may view this as a positive signal for the company's future performance and an opportunity for potential gains.

Read full article →